Doxycycline and Retinal vessel occlusion - a phase IV clinical study of FDA data

Summary:

Retinal vessel occlusion is reported as a side effect among people who take Doxycycline (doxycycline hyclate), especially for people who are male, 60+ old, also take Gilotrif, and have Dermatitis acneiform.

The phase IV clinical study analyzes which people have Retinal vessel occlusion when taking Doxycycline. It is created by eHealthMe based on reports of 57,458 people who have side effects when taking Doxycycline from the FDA, and is updated regularly.

What is Doxycycline?

Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 60,868 Doxycycline users. Check the latest studies of Doxycycline.

What is Retinal vessel occlusion?

Retinal vessel occlusion (a blockage in one of the small arteries) is found to be associated with 468 drugs and 831 conditions by eHealthMe. Check the latest studies of Retinal vessel occlusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

57,458 people reported to have side effects when taking Doxycycline.
Among them, 12 people (0.02%) have Retinal vessel occlusion.

Could Doxycycline cause Retinal vessel occlusion?

Among these 12 people:

What is the gender of people who have Retinal vessel occlusion when taking Doxycycline? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Retinal vessel occlusion when taking Doxycycline? *

What are other drugs people take besides Doxycycline? *

What are other side effects people have besides Retinal vessel occlusion? *

Blindness: 3 people, 25.00%
Visual Impairment: 3 people, 25.00%
Fall: 2 people, 16.67%
Cataract (clouding of the lens inside the eye): 2 people, 16.67%
Papilloedema (optic disc swelling): 2 people, 16.67%
Blindness Unilateral: 2 people, 16.67%
Retinal Infarction (retina damage due to less blood supply): 2 people, 16.67%
Retinal Vascular Disorder (a range of eye diseases that affect the blood vessels in the eye): 2 people, 16.67%
Ejection Fraction Decreased (systolic heart failure): 2 people, 16.67%
Eye Infection Fungal: 2 people, 16.67%

What are the existing conditions these people have? *

Lung Adenocarcinoma (a form of non-small cell lung cancer): 3 people, 25.00%
Pain: 3 people, 25.00%
Metastases To Bone (cancer spreads to bone): 3 people, 25.00%
Dermatitis Acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis): 3 people, 25.00%
Ocular Hypertension (intraocular pressure higher than normal): 2 people, 16.67%
Neuralgia (pain in one or more nerves): 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Intraocular Pressure Test Abnormal: 2 people, 16.67%
Fungal Infection: 2 people, 16.67%
Eye Infection Fungal: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Doxycycline and have Retinal vessel occlusion?

- Check whether Retinal vessel occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Doxycycline:

Doxycycline (60,868 reports)

Browse all side effects of Doxycycline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (468 drugs)

Browse all the conditions that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (831 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxycycline hyclate (the active ingredients of Doxycycline) and Doxycycline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.